JOHNSON & JOHNSON Long-Term Concentrated

Location: New Brunswick, NJ

CIK: 0000200406 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 10, 2022

Total Value: $391M (100.0% shares, 0.0% debt)

Holdings (22)

LEGN Legend Biotech Corporation 22.9%
Value $89.61M Shares 1,629,173 Share Price $55.00 Est. Cost/Share $41.61 Unrealized @ Report Date +32.2%
FATE Fate Therapeutics, Inc. 21.4%
Value $83.73M Shares 3,379,064 Share Price $24.78 Est. Cost/Share $78.44 Unrealized @ Report Date -68.4%
ARWR Arrowhead Pharmaceuticals, Inc. 11.3%
Value $44.4M Shares 1,260,869 Share Price $35.21 Est. Cost/Share $64.75 Unrealized @ Report Date -45.6%
PRCT Procept BioRobotics Corporation 8.5%
Value $33.29M Shares 1,018,478 Share Price $32.69 Est. Cost/Share $38.38 Unrealized @ Report Date -14.8%
MGTX MeiraGTx Holdings plc 5.6%
Value $21.94M Shares 2,898,550 Share Price $7.57 Est. Cost/Share $13.69 Unrealized @ Report Date -44.7%
CVRX CVRx, Inc. 5.4%
Value $21.01M Shares 3,495,575 Share Price $6.01 Est. Cost/Share $19.18 Unrealized @ Report Date -68.7%
XNCR Xencor, Inc. 5.2%
Value $20.47M Shares 748,062 Share Price $27.37 Est. Cost/Share $37.91 Unrealized @ Report Date -27.8%
PTGX Protagonist Therapeutics Inc. 4.9%
Value $19.37M Shares 2,449,183 Share Price $7.91 Est. Cost/Share $42.63 Unrealized @ Report Date -81.4%
HLTHQ Cue Health, Inc. 4.5%
Value $17.76M Shares 5,548,864 Share Price $3.20 Est. Cost/Share $11.81 Unrealized @ Report Date —
— Adicet Bio, Inc. 2.7%
Value $10.64M Shares 728,944 Share Price $14.60 Est. Cost/Share $7.84 Unrealized @ Report Date —
— Fusion Pharmaceuticals Inc. 2.3%
Value $9.14M Shares 3,670,516 Share Price $2.49 Est. Cost/Share $7.92 Unrealized @ Report Date —
— Point Biopharma Global Inc. 1.7%
Value $6.81M Shares 1,000,000 Share Price $6.81 Est. Cost/Share $7.69 Unrealized @ Report Date —
— Vor Biopharma, Inc. 1.4%
Value $5.341M Shares 1,074,658 Share Price $4.97 Est. Cost/Share $15.68 Unrealized @ Report Date —
NNOX Nano-X Imaging Ltd. 0.6%
Value $2.174M Shares 192,429 Share Price $11.30 Est. Cost/Share $20.72 Unrealized @ Report Date -45.5%
ALDX Aldeyra Therapeutics, Inc. 0.4%
Value $1.575M Shares 394,834 Share Price $3.99 Est. Cost/Share $9.18 Unrealized @ Report Date -56.5%
— BiomX Inc. 0.4%
Value $1.557M Shares 2,133,402 Share Price $0.73 Est. Cost/Share $3.06 Unrealized @ Report Date —
— SomaLogic, Inc. 0.3%
Value $1.27M Shares 281,052 Share Price $4.52 Est. Cost/Share $12.39 Unrealized @ Report Date —
— PhaseBio Pharmaceuticals, Inc. 0.2%
Value $964K Shares 1,607,044 Share Price $0.60 Est. Cost/Share $3.11 Unrealized @ Report Date —
— Tracon Pharmaceuticals, Inc. 0.0%
Value $168K Shares 84,003 Share Price $2.00 Est. Cost/Share $3.87 Unrealized @ Report Date —
— Catalyst Biosciences, Inc. 0.0%
Value $119K Shares 66,951 Share Price $1.78 Est. Cost/Share $4.11 Unrealized @ Report Date —
— Senseonics Holdings, Inc. 0.0%
Value $56,000 Shares 54,621 Share Price $1.03 Est. Cost/Share $3.39 Unrealized @ Report Date —
— Graybug Vision, Inc. 0.0%
Value $54,000 Shares 49,547 Share Price $1.09 Est. Cost/Share $3.31 Unrealized @ Report Date —